JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

Search

Globus Medical Inc (Class A)

Fermé

SecteurSoins de santé

89.62 -1.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

88.99

Max

90.63

Chiffres clés

By Trading Economics

Revenu

-84M

119M

Ventes

24M

769M

P/E

Moyenne du Secteur

30.091

90.422

BPA

1.18

Marge bénéficiaire

15.469

Employés

5,300

EBITDA

22M

215M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+17.45% upside

Dividendes

By Dow Jones

Prochains Résultats

24 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.3B

13B

Ouverture précédente

90.73

Clôture précédente

89.62

Sentiment de l'Actualité

By Acuity

71%

29%

324 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Globus Medical Inc (Class A) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 févr. 2026, 23:52 UTC

Acquisitions, Fusions, Rachats

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2 févr. 2026, 23:52 UTC

Acquisitions, Fusions, Rachats

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2 févr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2 févr. 2026, 23:38 UTC

Market Talk

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2 févr. 2026, 23:28 UTC

Market Talk

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2 févr. 2026, 23:23 UTC

Résultats

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2 févr. 2026, 22:57 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2 févr. 2026, 22:08 UTC

Market Talk

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2 févr. 2026, 21:51 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 févr. 2026, 21:49 UTC

Résultats

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2 févr. 2026, 21:39 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:36 UTC

Résultats

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2 févr. 2026, 21:34 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:28 UTC

Acquisitions, Fusions, Rachats

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2 févr. 2026, 21:23 UTC

Résultats

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2 févr. 2026, 21:19 UTC

Résultats

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2 févr. 2026, 21:17 UTC

Résultats

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2 févr. 2026, 21:17 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:10 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:08 UTC

Résultats

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2 févr. 2026, 21:07 UTC

Résultats

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q Net $608.7M >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q Rev $1.41B >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q Adj EPS 25c >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q EPS 24c >PLTR

2 févr. 2026, 20:40 UTC

Market Talk

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Comparaison

Variation de prix

Globus Medical Inc (Class A) prévision

Objectif de Prix

By TipRanks

17.45% hausse

Prévisions sur 12 Mois

Moyen 106.5 USD  17.45%

Haut 118 USD

Bas 87 USD

Basé sur 14 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

14 ratings

11

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

72.18 / 73.07Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

324 / 352Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat